Trump Administration Proposes Federal Nondisclosure Agreement Policy International Aid Sector Faces Breaking Point as Legacy Models Struggle Under Funding Pressures Latin American Leaders Call for Housing Finance Overhaul and ClimateResilient Urban Development at WUF13 Buffetts Tiny Purchase Hinted at in March Berkshire Filing Suggests Small New Position Young American Men Drive Surge in Prediction Market Activity for HighRisk HighReward Bets Bessent Predicts Substantial Disinflation as Fed Transition Under Warsh Begins National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Sees Slight Decline GDS Holdings Q1 2026 Earnings Stunning EPS Beat of 132 vs Expected Loss Biodesix BDSX Q1 2026 Earnings Significant EPS Beat Driven by Narrowing Losses CBAN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment RYM Q3 2022 Earnings Deep Earnings Miss Amid Negative Surprise Sprout Social Inc SPT Q1 2026 Earnings EPS Beats Estimates by Wide Margin StableX Technologies SBLX Holds Steady at 31 as Market Awaits Direction ProQR Therapeutics PRQR Soars 83 Analyzing the Rally and Key Levels to Watch Champions Oncology CSBR Gains 159 as Stock Approaches Key Resistance Level HysterYale Inc HY Gains 183 as Stock Finds Support Above 32 Woodside Energy WDS Edges Lower as Energy Sector Faces Mixed Signals Fluent Inc Q1 2026 Earnings EPS Surprises Above Estimates Amid Narrowed Loss GSBC Q1 2026 Earnings Strong EPS Beat Despite Slight Stock Decline TIGR Q4 2025 Earnings EPS Beats Estimates as Stock Plunges 25 Datasea Inc DTSS Q2 2022 Earnings Substantial EPS Miss as Stock Rises on Uncertain Outlook MicroVision Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Revenue Absence Trump Administration Tightens Green Card Process Foreign Nationals May Need to Leave US for Applications PEW Q1 2026 Earnings NarrowerThanExpected Loss Fails to Boost Sentiment VirnetX Holding Corp VHC Edges Higher as PatentLitigation Stock Tests Key Resistance CLNN Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Ongoing Clinical Progress Soluna Holdings Q4 2025 Earnings EPS Misses Estimates as Revenue Remains Absent NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20 TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales Ferrovial SE FER Q4 2025 Earnings EPS Beats Estimates by 526 Shares Edge Lower NLY Q1 2026 Earnings Modest EPS Beat as Mortgage REIT Faces Steady Rate Environment AEMD Q1 2026 Earnings Slightly Better Than Expected Loss Amid No Revenue